REPL
Replimune Group, Inc. · Healthcare · Market cap $1.1B
Insiders sold $1.1M net in the last 90 days ·5 sellers, 0 buyers· 1 of 6 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 19, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Aug 24, 2026
Hill Emily Luisa
Replimune Group, Inc. (REPL) has 30 SEC Form 4 filings (31 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 24, 2026.
Inside the rolling window, 7 insiders at Replimune Group, Inc. reported no open-market purchases and 17 open-market sales totaling $1.9M. The most active filer is Chief Commercial Officer Sarchi Christopher with 4 filings. Insiders have net sold $1.7M over the trailing 6 months. The most recent open-market filing is a sale of 9,256 shares by Chief Financial Officer Hill Emily Luisa, dated Aug 17, 2026, worth $132K.
- Industry:Biotechnology
- CEO:Sushil Patel
- Employees:465
- HQ:Woburn, MA, US
- IPO:2018-07-20
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Financial Officer | Sale | 9,256 | $132K | Aug 19 | -20.9% | SEC ↗ | |
| Chief Medical Officer | Sale | 11,447 | $148K | Aug 12 | -23.1% | SEC ↗ | |
| Chief Executive Officer | Sale | 39,341 | $510K | Aug 12 | -23.1% | SEC ↗ | |
| Chief Accounting Officer | Sale | 7,632 | $99K | Aug 12 | -23.1% | SEC ↗ | |
| Chief Financial Officer | Sale | 11,448 | $148K | Aug 12 | -23.1% | SEC ↗ | |
| Chief Commercial Officer | Sale | 12,000 | $111K | Jun 4 | +18.7% | SEC ↗ | |
Xynos KonstantinosFirst in 6 months | Chief Medical Officer | Sale | 14,023 | $71K | May 20 | +127.1% | SEC ↗ |
Hill Emily LuisaFirst filing | Chief Financial Officer | Sale | 7,812 | $40K | May 20 | +127.1% | SEC ↗ |
| Chief Commercial Officer | Sale | 8,626 | $44K | May 20 | +127.1% | SEC ↗ | |
Astley-Sparke PhilipFirst filing | Director | Sale | 17,657 | $90K | May 20 | +127.1% | SEC ↗ |
Patel SushilFirst in 6 months | Chief Executive Officer | Sale | 37,324 | $190K | May 20 | — | SEC ↗ |
Schwendenman AndrewFirst filing | Chief Accounting Officer | Sale | 7,894 | $40K | May 20 | — | SEC ↗ |
Sarchi ChristopherFirst in 5 months | Chief Commercial Officer | Sale | 6,500 | $52K | Apr 6 | — | SEC ↗ |
Dhingra KapilFirst filing | Director | Sale | 3,169 | $33K | Dec 11 | — | SEC ↗ |
Patel SushilFirst filing | Chief Executive Officer | Sale | 10,000 | $111K | Dec 4 | — | SEC ↗ |
Sarchi ChristopherFirst filing | Chief Commercial Officer | Sale | 5,208 | $47K | Nov 19 | — | SEC ↗ |
Xynos KonstantinosFirst filing | Chief Medical Officer | Sale | 7,248 | $66K | Nov 19 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does REPL have?
Replimune Group, Inc. (REPL) has 30 SEC Form 4 filings (31 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Aug 24, 2026.
When was the most recent SEC Form 4 filing for REPL?
The most recent Form 4 filing for REPL on Tracefour is dated Aug 24, 2026.
Who is the most active insider at REPL?
The most active SEC Form 4 filer at REPL in the rolling window is Chief Commercial Officer Sarchi Christopher, with 4 filings.
What is the net insider flow at REPL over the last 6 months?
Over the trailing 180 days, insiders at REPL have net sold $1.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at REPL in the current window?
Inside the rolling window, insiders at REPL bought $0 and sold $1.9M based on SEC Form 4 filings.
Can I get alerts for REPL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Replimune Group, Inc. (REPL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Replimune Group, Inc. is in the Healthcare sector.